3 Year return
20.84%Investment Details
Calculate Returns
Based on past performance of this fund
Risk Involved
Your principal will be at
Very High Risk
Asset Under Management
₹8647.95 Cr.
Expense Ratio
0.9% (inclusive of GST)
Exit Load
1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.
Tax Implications
Withdrawal within 1 year:
20% tax on gains
Withdrawal after 1 year:
12.5% tax on gains above ₹1.25 lakh per financial year
Fund Holdings
Nippon India Mutual Fund Managers
SB
Sailesh Raj Bhan
Fund Manager since May 2018
Fund House Details
Nippon India Mutual Fund Asset management company
Peer Comparison
Comparison with other similar funds
Funds
|
3 Y Returns
|
ARQ Rating
|
---|---|---|
Quant Infrastructure Fund |
29.84% |
0 |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund |
23.91% |
0 |
DSP Healthcare Fund |
22.23% |
0 |
Schemes by Nippon India Mutual Fund
List of mutual fund schemes by AMC
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan Monthly IDCW Payout
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan Monthly IDCW Reinvestment
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan IDCW Payout
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan IDCW Reinvestment
Hybrid . Arbitrage Fund
Nippon India Arbitrage Fund Direct Plan Growth
About Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment
Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is managed by Nippon Life India Asset Management Limited, formerly known as Reliance Nippon Life Asset Management Limited. Categorised as Sectoral/Thematic Funds, this fund focuses on investing in companies within a specific sector or theme, in this case, the pharmaceutical sector. Sectoral funds like this one concentrate on specific industries, aiming to benefit from the growth potential of that sector. Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is an open-ended fund, meaning investors can buy or sell units of the fund at any time, within market hours.
Investment Objective of the Scheme
The primary investment objective of the Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is to seek long-term capital appreciation by primarily investing in equity and equity-related securities of companies in the pharmaceutical sector.
Key Features of The Fund
5-year return | 32.13% |
Expense Ratio | 0.9% |
Fund Manager | Sailesh Raj Bhan |
Fund Size | ₹8647.95 Cr |
Risk Profile | Very High |
Is This Scheme Right for Me?
This fund might be suitable for investors who have a positive outlook on the pharmaceutical sector and want to allocate a portion of their funds to this specific industry. Sectoral funds can offer higher potential returns but also come with concentrated risk. So, investors with low-risk tolerance should not consider this fund. Interested investors should also bear in mind the potential volatility of the pharmaceutical sector before making a decision.
AMC Contact Details
Name | Nippon India Mutual Fund |
Launch Date | June 1995 |
Addresss | Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013 |
Contact | 1860 266 0111 |
customercare@nipponindiaim.in | |
Website | https://mf.nipponindiaim.com/ |
Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.
Invest Smart, Start Your SIP Today
FAQs
What is today's NAV of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
What is the AUM of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
What is the expense ratio of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
What are the returns of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment since inception?
What is the minimum SIP amount to invest in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
How do I invest in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Make sure you are logged in to Angel One.
- Select the type of investment: SIP or one-time.
- In case of an SIP, select the amount and date and click ‘Start SIP’. In case of a one-time investment, enter just the amount.
- Proceed by clicking the pay button and choosing your mode of payment.
- Your portfolio will be updated with this investment in 3-5 working days.
How to start an SIP in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Click on the ‘Invest’ button.
- Enter your desired SIP amount and the SIP date.
- You can uncheck the ‘Make first payment now’ box if you don’t want to make the payment right away.
- Choose your payment method between UPI and Net Banking.
- Make your payment.
- Your SIP is created.
How do I automate an SIP in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Once you create an SIP, click on ‘Set up autopay’
- Select your desired verification method - debit card, net banking or Aadhar method credentials - and click on submit.
- Once you verify the OTP, your mandate request will be created.
How can I withdraw/redeem my investment in Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?
- Go to the ‘Investments’ section and click on the mutual fund scheme you want to withdraw.
- Enter the amount you want to withdraw and tap the ‘Withdraw’ button.
- Verify the details on the ‘Confirm withdraw’ screen.
- Select the bank account in which you want to receive the funds.
- You will receive your funds within three working days of placing the order.
- You can track your order in the ‘Orders’ section.